Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit

NCT00271752 is registered in ClinicalTrials.gov with Danish Procalcitonin Study Group as lead sponsor.

NCT NCT00271752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00271752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Procalcitonin and Survival Study - A Multicentre Single Blinded Randomized Controlled Trial to Investigate if Treatment Guided by Daily Procalcitonin Measurements Can Reduce Mortality in the Intensive Care Unit
Lead sponsor
Danish Procalcitonin Study Group
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2006
Completion date
September 30, 2009
Enrollment
1,200 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

localized infection, multiple organ failure, sepsis